Lotus Neuro Proof of Pharmacology Challenge · 2026
2026 Proof of Pharmacology Challenge · Full Proposal Submission

Congratulations — you've been selected to submit a full proposal.

Your center cleared every eligibility gate and your one-page summary advanced through committee review. Complete the contact information below and upload your four proposal documents to finish your submission.

Full proposal dueAugust 2, 2026 · 11:59 PM ET
Documents requiredFour (4)
NotificationBy August 15, 2026
First patient byDecember 2026

01 — CONTACT

Tell us who's submitting

The principal investigator listed here becomes our primary contact for contracting, regulatory follow-up, and notification of results.

Site & investigator details

Contact information

02 — DOCUMENTS

Upload your four proposal documents

Keep each tight — the review committee reads dozens of applications. The first three are required; the letter of support is optional if you are testing a homegrown molecule.

01

Study Proposal

6 pages maximum

The scientific and operational case for adding a FUS arm to your existing trial.

02

References

2 pages maximum

Citations supporting the rationale and methodology in Document #1.

03

Budget

single PDF

Itemized cost breakdown for the FUS arm — device time, staff, imaging, monitoring, regulatory.

04

Letter of Support

single PDF · optional

From the biopharma collaborator providing the asset. Skip this if you are testing a homegrown molecule.

Document #1 · Study Proposal

Required information for the 6-page study proposal

01
Scientific rationale for asset + FUS combo

What is the scientific evidence to date that suggests FUS could enhance brain delivery of the specific asset?

02
Safety risk assessment of asset + FUS combo

What is the rationale to support the safety profile of asset dose + FUS?

03
Study plan

What are the study details incorporating a FUS arm into the ongoing trial?

04
Biomarker plan

How will TE, PK, and/or PD be detected and measured?

05
Patient recruitment

How many patients are required to sufficiently power the study? What are the plans and expectations for patient access and recruitment?

06
Overall logistics

What is the timeline and budget for the proposed study? What are the key logistical milestones leading up to first-patient enrollment?

Submitting sends your documents to the review committee. You'll receive an email confirmation, and notification of results by August 15, 2026.
03 — TIMELINE

What happens next

Dates from here to first-patient enrollment. Late submissions cannot be reviewed.

Full proposal due
August 2, 2026 · 11:59 PM ET
Committee review
August 3 – 14, 2026
Notification of results
By August 15, 2026
Paperwork completion
September – November 2026
First patient enrolled
December 2026
Reference document

Download the full Request for Proposals.

The official RFP includes the complete submission timeline, evaluation criteria, and contracting framework. Review before submitting.

PDF · 194 KB
Version · 2026.1
Download RFP